GE HealthCare has partnered with DeepHealth, a subsidiary of RadNet, to enhance its AI capabilities in medical imaging. The collaboration aims to develop SmartTechnology solutions that leverage AI to improve the efficiency of imaging interpretation and reporting, clinical assessments, and inter-team collaboration in breast cancer diagnostics.
The integration of AI into medical imaging is rapidly transforming the healthcare landscape, with the global revenue for AI platforms in healthcare projected to reach $18.8 billion by 2027.
The initial focus of the partnership will be on breast cancer detection, utilizing DeepHealth's AI-driven SmartMammo platform. This software-as-a-service solution is designed to seamlessly integrate into existing breast cancer diagnostic workflows, enhancing both efficiency and accuracy in detection. By combining SmartMammo with GE HealthCare's advanced 3D mammography tool, the collaboration aims to introduce AI-driven clinical imaging into breast cancer screening processes.
The partnership will also introduce Smart Alerts to the Senographe Pristina system, which will promptly notify imaging sites of cases with potentially suspicious lesions, facilitating same-day diagnostic exams and improving follow-up compliance.
The collaboration between GE HealthCare and DeepHealth aims to revolutionize large-scale diagnostic and screening programs by streamlining radiology workflows and empowering healthcare providers with advanced tools. This initiative aligns with the broader trend of integrating AI into healthcare to enhance diagnostic accuracy and operational efficiency.